Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone

J W C Alffenaar; C A Peloquin; G B Migliori

doi:10.5588/ijtld.17.0632

Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone

J W C Alffenaar, C A Peloquin, G B Migliori

Microbes in Health and Disease (MHD)

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

4 Citations (Scopus)

56 Downloads (Pure)

Original language	English
Pages (from-to)	2-2
Number of pages	1
Journal	International Journal of Tuberculosis and Lung Disease
Volume	22
Issue number	1
DOIs	https://doi.org/10.5588/ijtld.17.0632
Publication status	Published - 1-Jan-2018

Keywords

Journal Article
TUBERCULOSIS

Access to Document

10.5588/ijtld.17.0632

Making optimal use of available anti-tuberculosis drugsFinal publisher's version, 32.5 KBLicence: Taverne

Handle.net

Persistent link

Cite this

@article{f626927a1eca400aaf0437e595fd4c52,

title = "Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone",

keywords = "Journal Article, TUBERCULOSIS",

author = "Alffenaar, {J W C} and Peloquin, {C A} and Migliori, {G B}",

year = "2018",

month = jan,

day = "1",

doi = "10.5588/ijtld.17.0632",

language = "English",

volume = "22",

pages = "2--2",

journal = "International Journal of Tuberculosis and Lung Disease",

issn = "1027-3719",

publisher = "International Union against Tubercul. and Lung Dis.",

number = "1",

}

TY - JOUR

T1 - Making optimal use of available anti-tuberculosis drugs

T2 - first steps to investigate terizidone

AU - Alffenaar, J W C

AU - Peloquin, C A

AU - Migliori, G B

PY - 2018/1/1

Y1 - 2018/1/1

KW - Journal Article

KW - TUBERCULOSIS

U2 - 10.5588/ijtld.17.0632

DO - 10.5588/ijtld.17.0632

M3 - Comment/Letter to the editor

C2 - 29297417

SN - 1027-3719

VL - 22

SP - 2

EP - 2

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

IS - 1

ER -